Lamet M - Search Results

Year	Number of Results
1979	1
1985	1
1994	1
2001	1
2005	1
2009	2
2010	1
2011	2
2016	1
2017	1
2018	1
2022	1
2024	0

1

Treatment of Early-Stage Alzheimer's Disease With CT Scans of the Brain: A Case Report.

Cuttler JM, Lamet MS, Calabrese EJ. Cuttler JM, et al. Among authors: lamet ms. Dose Response. 2022 Mar 18;20(1):15593258221078392. doi: 10.1177/15593258221078392. eCollection 2022 Jan-Mar. Dose Response. 2022. PMID: 35321237 Free PMC article.

2

Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss.

Agnihotri A, Xie A, Bartalos C, Kushnir V, Sullivan S, Islam S, Islam E, Lamet M, Lamet A, Farboudmanesch R, Overholt BF, Altawil J, Early DS, Bennett M, Lowe A, Mullady DK, Adeyeri CS, El Zein M, Mishra P, Fayad L, Dunlap M, Oberbach A, Cheskin LJ, Kalloo AN, Khashab MA, Kumbhari V. Agnihotri A, et al. Among authors: lamet m. Clin Gastroenterol Hepatol. 2018 Jul;16(7):1081-1088.e1. doi: 10.1016/j.cgh.2018.02.026. Epub 2018 Mar 2. Clin Gastroenterol Hepatol. 2018. PMID: 29481969

3

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Pimentel M, et al. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. N Engl J Med. 2011. PMID: 21208106 Free article. Clinical Trial.

4

Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P; Latino Study Group. Rodriguez-Torres M, et al. N Engl J Med. 2009 Jan 15;360(3):257-67. doi: 10.1056/NEJMoa0805062. N Engl J Med. 2009. PMID: 19144941 Free article. Clinical Trial.

5

Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.

Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP. Scherl EJ, et al. Among authors: lamet m. Am J Gastroenterol. 2009 Jun;104(6):1452-9. doi: 10.1038/ajg.2009.83. Epub 2009 Apr 21. Am J Gastroenterol. 2009. PMID: 19491859 Clinical Trial.

6

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.

Murray JA, Kelly CP, Green PHR, Marcantonio A, Wu TT, Mäki M, Adelman DC; CeliAction Study Group of Investigators. Murray JA, et al. Gastroenterology. 2017 Mar;152(4):787-798.e2. doi: 10.1053/j.gastro.2016.11.004. Epub 2016 Nov 15. Gastroenterology. 2017. PMID: 27864127 Clinical Trial.

7

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B. Johnson DA, et al. Among authors: lamet m. Am J Gastroenterol. 2001 Jan;96(1):27-34. doi: 10.1111/j.1572-0241.2001.03443.x. Am J Gastroenterol. 2001. PMID: 11197282 Clinical Trial.

8

A technique for performing transesophageal echocardiography safely in patients with Zenker's diverticulum.

Willens HJ, Lamet M, Migikovsky B, Kessler KM. Willens HJ, et al. Among authors: lamet m. J Am Soc Echocardiogr. 1994 Sep-Oct;7(5):534-7. doi: 10.1016/s0894-7317(14)80012-6. J Am Soc Echocardiogr. 1994. PMID: 7986551 Free article.

9

A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

Lamet M. Lamet M. Dig Dis Sci. 2011 Feb;56(2):513-22. doi: 10.1007/s10620-010-1334-y. Epub 2010 Jul 30. Dig Dis Sci. 2011. PMID: 20676771 Free PMC article. Clinical Trial.

10

Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.

Lamet M, Ptak T, Dallaire C, Shah U, Grace M, Spenard J, de Montigny D; Mesalamine Study Group. Lamet M, et al. Inflamm Bowel Dis. 2005 Jul;11(7):625-30. doi: 10.1097/01.mib.0000171277.70404.40. Inflamm Bowel Dis. 2005. PMID: 15973115 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year